Watchlist Price Alert

Connect Biopharma Limite... (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

1.06

0.08 (8.17%)

At close: Jun 17, 2025, 3:59 PM

1.08

1.85%

After-hours: Jun 17, 2025, 07:32 PM EDT

Connect Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019
Revenue	1.91M	24.12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	183.53K	476K	481.87K	506.13K	527.3K	503.34K	412.05K	221.39K	n/a	n/a	n/a	n/a
Gross Profit	1.73M	23.64M	-481.87K	-506.13K	-527.3K	-503.34K	-412.05K	-221.39K	n/a	n/a	n/a	n/a
Operating Income	-24.91M	7.31M	-27.23M	-34.84M	-54.28M	-63.38M	-58.26M	-41.09M	-19.65K	-8.98K	-8M	-8M
Interest Income	4.03M	822K	-2.49M	2.49M	1.29M	271.1K	54.89	22.92	375.32	133.89	77.33K	77.33K
Pretax Income	-23.05M	7.71M	-28.87M	-30.52M	-56.49M	-59.63M	-56.39M	-145.71M	-107.85K	-10.64K	-12.23M	-12.23M
Net Income	-23.22M	7.65M	-28.92M	-30.58M	-56.68M	-59.74M	-56.65M	-145.71M	-107.85K	-10.64K	-12.01M	-12.01M
Selling & General & Admin	10.74M	7.43M	5.92M	7.61M	9.16M	11.21M	11.17M	7.19M	6.22K	1K	704.57K	704.57K
Research & Development	15.9M	13.32M	25.18M	26.73M	44.6M	50.66M	46.68M	33.67M	14.08K	8.36K	7.72M	7.72M
Other Expenses	n/a	-3.94M	-4.35M	n/a	n/a	-940.31K	n/a	n/a	n/a	n/a	-205.72K	-205.72K
Operating Expenses	26.63M	16.81M	27.74M	34.34M	53.76M	60.93M	57.85M	40.87M	107.47K	10.78K	8.22M	8.22M
Interest Expense	n/a	20K	-10.39K	10.39K	12.32K	8.72K	n/a	n/a	n/a	n/a	3.84K	3.84K
Selling & Marketing Expenses	n/a	n/a	5.94M	7.58M	9.12M	-9.12M	11.16M	7.19M	4.60	n/a	n/a	n/a
Cost & Expenses	-26.82M	16.81M	27.23M	34.84M	54.28M	60.4M	58.26M	41.09M	107.47K	10.78K	8.22M	8.22M
Income Tax Expense	162.58K	60K	55.22K	64.78K	186.17K	111.34K	263.87K	n/a	n/a	n/a	-221.24K	-221.24K
Shares Outstanding (Basic)	55.19M	55.14M	55.07M	55.05M	55.02M	55.02M	53.74M	46.94M	17.09M	17.09M	55.82M	55.82M
Shares Outstanding (Diluted)	55.19M	55.55M	55.07M	55.05M	55.02M	55.02M	53.74M	46.94M	17.09M	17.09M	55.82M	55.82M
EPS (Basic)	-0.42	0.14	-0.52	-0.56	-1.03	-13.47	-1.05	-3.1	-6.32	-0.62	-1.51	-1.51
EPS (Diluted)	-0.42	0.14	-0.52	-0.56	-1.03	-13.47	-1.05	-3.1	-6.32	-0.62	-1.51	-1.51
EBITDA	-22.87M	8.2M	-28.37M	-30M	-53.76M	-57.55M	-57.85M	-40.87M	-19.53M	-8.95M	-12.39M	-12.39M
EBIT	-23.05M	7.72M	-28.85M	-30.51M	-56.48M	-61.56M	-56.39M	-20.58M	-19.65M	-8.98M	-12.2M	-12.2M
Depreciation & Amortization	183.53K	476K	481.87K	506.13K	527.3K	486.34K	412.05K	221.39K	118.11	27.03	57.3K	57.3K